Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03028025 · ClinicalTrials.gov registry record · NA

Comparing TR Band to Statseal in Conjunction With TR Band

A NA study of Cardiovascular Diseases and Coronary Artery Disease, sponsored by VA Long Beach Healthcare System.

Completed
Registry status
NA
Development phase
184
Enrollment target
1
Study location

NCT03028025 is a NA study of Cardiovascular Diseases and Coronary Artery Disease that has completed, run by VA Long Beach Healthcare System. The registered enrollment target is 184 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03028025, a NA study of Cardiovascular Diseases and Coronary Artery Disease, has completed, sponsored by VA Long Beach Healthcare System.

COMPLETED
Registry status
NA
Development phase
184 participants
Enrollment target
1
Study location

Study Summary

The primary objectives of this study are to evaluate the performance of StatSeal Advanced used in conjunction with the TR Band (SSA) as compared to the TR Band without SSA (TRB) relative to: the incidence of peri-procedural radial artery occlusion (RAO) at discharge or 24 hours, whichever occurs first, and the Time to Hemostasis (TTH).

Interventions

  • DEVICE StatSeal
  • DEVICE TR Band

Study Locations (1)

California

  • Veteran Affairs Long Beach - Long Beach

Trial Details

FieldValue
Enrollment Target 184 participants
Start Date 2017-01-01
Est. Completion 2017-08-01
Phase NA

Sponsor

VA Long Beach Healthcare System

2 total trials

What the Registry Record Tells You About NCT03028025

The ClinicalTrials.gov registry entry for NCT03028025 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The listed sponsor is VA Long Beach Healthcare System, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which StatSeal is the first listed.

NCT03028025 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03028025 about?

NCT03028025 is a clinical study titled "Comparing TR Band to Statseal in Conjunction With TR Band". The primary objectives of this study are to evaluate the performance of StatSeal Advanced used in conjunction with the TR Band (SSA) as compared to the TR Band without SSA (TRB) relative to: the incidence of peri-procedural radial artery occlusion (RAO) at discharge or 24 hours, whichever occurs fir...

What is the current status of trial NCT03028025?

This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2017-01-01. Estimated completion is 2017-08-01.

What conditions does trial NCT03028025 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Coronary Artery Disease, Atherosclerosis, Angina Pectoris, Arterial Occlusion.

What interventions are being tested in trial NCT03028025?

The interventions under investigation include: StatSeal (DEVICE), TR Band (DEVICE).

Who is sponsoring clinical trial NCT03028025?

This trial is sponsored by VA Long Beach Healthcare System, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03028025 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.